Recognition of LPS by TLR4: Potential for Anti-Inflammatory Therapies

by Reindert Nijland, Tom Hofland, Jos A. G. van Strijp
Published 2014-07-01

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia

by Tom Hofland, Eric Eldering, Arnon P. Kater, Sanne H. Tonino
Published 2019-09-01

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

by Cameron L. Lilly, Nancy Y. Villa, Ana Lemos de Matos, Haider M. Ali, Jess-Karan S. Dhillon, Tom Hofland, Masmudur M. Rahman, Winnie Chan, Bjarne Bogen, Christopher Cogle, Grant McFadden
Published 2017-03-01

Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL

by Tom Hofland, Iris de Weerdt, Sanne Endstra, Aldo Jongejan, Laura Platenkamp, Ester B.M. Remmerswaal, Perry D. Moerland, Ineke J.M. ten Berge, Mark-David Levin, Arnon P. Kater, Sanne H. Tonino
Published 2020-04-01

Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling

by Tom Hofland, Sanne Endstra, Calum K.P. Gomes, Renate de Boer, Iris de Weerdt, Vladimir Bobkov, Jurgen A. Riedl, Raimond Heukers, Martine J. Smit, Eric Eldering, Mark-David Levin, Arnon P. Kater, Sanne H. Tonino
Published 2019-12-01